As of 2026-03-20, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (67.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -81166.6%.
The range of the Relative Valuation is (64.13) - (74.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 27.4x | 24.5x |
| Forward P/E multiples | 21.4x - 25.8x | 22.0x |
| Fair Price | (64.13) - (74.78) | (67.29) |
| Upside | -77366.0% - -90197.2% | -81166.6% |
| Date | P/E |